Five Years Follow-up of Riboflavin/Ultraviolet A (370 nm) Corneal Collagen Cross-linking to Halt the Progression of Keratoconus

PS David O'Brart, Parul Patel, Naomi A O'Brart
2014 International Journal of Keratoconus and Ectatic Corneal Diseases  
Aims: To determine the long-term efficacy and safety of riboflavin/ultraviolet a corneal cross-linking (CXL) to halt the progression of keratoconus. Materials and methods: Thirty-five patients (35 eyes) who had undergone CXL with epithelial removal 5 or more years previously were examined.
doi:10.5005/jp-journals-10025-1081 fatcat:in7oxcc43fffrpjg24lkphsxka